Singapore markets closed

Heart Test Laboratories, Inc. (HSCS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.74+0.19 (+3.42%)
At close: 04:00PM EDT
5.82 +0.05 (+0.87%)
Pre-market: 08:58AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.76M
Enterprise value -2.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)65.80
Price/book (mrq)0.44
Enterprise value/revenue 1.12k
Enterprise value/EBITDA -1.81

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-94.37%
S&P500 52-week change 324.52%
52-week high 3110.00
52-week low 35.10
50-day moving average 38.87
200-day moving average 322.77

Share statistics

Avg vol (3-month) 346.62k
Avg vol (10-day) 384.66k
Shares outstanding 5655.62k
Implied shares outstanding 6655.62k
Float 8562.01k
% held by insiders 116.01%
% held by institutions 12.37%
Shares short (15 May 2024) 43.08k
Short ratio (15 May 2024) 40.1
Short % of float (15 May 2024) 40.48%
Short % of shares outstanding (15 May 2024) 40.47%
Shares short (prior month 15 Apr 2024) 46k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 317 May 2024

Financial highlights

Fiscal year

Fiscal year ends 30 Apr 2023
Most-recent quarter (mrq)31 Jan 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-10,376.75%

Management effectiveness

Return on assets (ttm)-52.73%
Return on equity (ttm)-152.61%

Income statement

Revenue (ttm)18.6k
Revenue per share (ttm)0.09
Quarterly revenue growth (yoy)653.80%
Gross profit (ttm)N/A
EBITDA -6M
Net income avi to common (ttm)-6.39M
Diluted EPS (ttm)-35.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.08M
Total cash per share (mrq)10.79
Total debt (mrq)1.06M
Total debt/equity (mrq)12.27%
Current ratio (mrq)5.09
Book value per share (mrq)13.57

Cash flow statement

Operating cash flow (ttm)-6.4M
Levered free cash flow (ttm)-4.89M